A rapid survival assay to measure drug-induced cytotoxicity and cell cycle effects

被引:17
作者
Valiathan, Chandni [2 ,4 ]
McFaline, Jose L. [3 ,4 ]
Samson, Leona D. [1 ,2 ,3 ,4 ]
机构
[1] MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[2] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA
[3] MIT, Dept Biol, Cambridge, MA 02139 USA
[4] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA
关键词
Clonogenic survival assay; Cell cycle; Flow cytometry; CENTRAL-NERVOUS-SYSTEM; HIGH-DOSE BCNU; FLOW-CYTOMETRY; ALKYLATING-AGENTS; GLIOMA-CELLS; CROSS-LINK; DNA; METHYLTRANSFERASE; TEMOZOLOMIDE; APOPTOSIS;
D O I
10.1016/j.dnarep.2011.11.002
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We describe a rapid method to accurately measure the cytotoxicity of mammalian cells upon exposure to various drugs. Using this assay, we obtain survival data in a fraction of the time required to perform the traditional clonogenic survival assay, considered the gold standard. The dynamic range of the assay allows sensitivity measurements on a multi-log scale allowing better resolution of comparative sensitivities. Moreover, the results obtained contain additional information on cell cycle effects of the drug treatment. Cell survival is obtained from a quantitative comparison of proliferation between drug-treated and untreated cells. During the assay, cells are treated with a drug and, following a recovery period, allowed to proliferate in the presence of bromodeoxyuridine (BrdU). Cells that synthesize DNA in the presence of BrdU exhibit quenched Hoechst fluorescence, easily detected by flow cytometry: quenching is used to determine relative proliferation in treated vs. untreated cells. Finally, this assay can be used in high-throughput format to simultaneously screen multiple cell lines and drugs for accurate measurements of cell survival and cell cycle effects after drug treatment. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 98
页数:7
相关论文
共 26 条
  • [1] PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
    Bleau, Anne-Marie
    Hambardzumyan, Dolores
    Ozawa, Tatsuya
    Fomchenko, Elena I.
    Huse, Jason T.
    Brennan, Cameron W.
    Holland, Eric C.
    [J]. CELL STEM CELL, 2009, 4 (03) : 226 - 235
  • [2] High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients
    Durando, X
    Lemaire, JJ
    Tortochaux, J
    Van-Praagh, I
    Kwiatkowski, F
    Vincent, C
    Bailly, C
    Verrelle, P
    Irthum, B
    Chazal, J
    Bay, JO
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 (07) : 559 - 564
  • [3] Genomic predictors of interindividual differences in response to DNA damaging agents
    Fry, Rebecca C.
    Svensson, J. Peter
    Valiathan, Chandni
    Wang, Emma
    Hogan, Brad J.
    Bhattacharya, Sanchita
    Bugni, James M.
    Whittaker, Charles A.
    Samson, Leona D.
    [J]. GENES & DEVELOPMENT, 2008, 22 (19) : 2621 - 2626
  • [4] Activation of inflammation/NF-κB signaling in infants born to arsenic-exposed mothers
    Fry, Rebecca C.
    Navasumrit, Panida
    Valiathan, Chandni
    Svensson, J. Peter
    Hogan, Bradley J.
    Luo, Manlin
    Bhattacharya, Sanchita
    Kandjanapa, Krittinee
    Soontararuks, Sumitra
    Nookabkaew, Sumontha
    Mahidol, Chulabhorn
    Ruchirawat, Mathuros
    Samson, Leona D.
    [J]. PLOS GENETICS, 2007, 3 (11): : 2180 - 2189
  • [5] MGMT: Its role in cancer aetiology and cancer therapeutics
    Gerson, SL
    [J]. NATURE REVIEWS CANCER, 2004, 4 (04) : 296 - 307
  • [6] GOLDMACHER VS, 1986, J BIOL CHEM, V261, P2462
  • [7] GONZAGA PE, 1992, CANCER RES, V52, P6052
  • [8] Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
    Hickman, MJ
    Samson, LD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) : 10764 - 10769
  • [9] HIGH-DOSE BCNU WITH AUTOLOGOUS BONE-MARROW RESCUE FOR RECURRENT GLIOBLASTOMA-MULTIFORME
    HOCHBERG, FH
    PARKER, LM
    TAKVORIAN, T
    CANELLOS, GP
    ZERVAS, NT
    [J]. JOURNAL OF NEUROSURGERY, 1981, 54 (04) : 455 - 460
  • [10] KAINA B, 1991, CARCINOGENESIS, V12, P1857